Business · 12/03/2021Updated: 10/17/2026 · 1 min read
FDA Corrects Notice on Withdrawal of 10 Abbreviated New Drug Applications from VistaPharm, Inc.
Summary
The FDA is correcting a notice that announced the withdrawal of approval of 10 abbreviated new drug applications, including two from VistaPharm, Inc., after receiving a withdrawal request. The FDA has reinstated the approval of these applications due to timely requests from VistaPharm, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →